Anavex Life Sciences (AVXL) Shares Outstanding (Weighted Average) (2010 - 2025)

Anavex Life Sciences' Shares Outstanding (Weighted Average) history runs 16 years deep, the most recent figure standing at $89.0 million for Q4 2025.

• In Q4 2025, Shares Outstanding (Weighted Average) rose 4.98% year-over-year to $89.0 million; the TTM figure through Dec 2025 stood at $89.0 million (up 4.98% YoY), while the FY2025 annual figure was $10000.0, changed 0.0% from the prior year.
• Shares Outstanding (Weighted Average) came in at $89.0 million for Q4 2025 at Anavex Life Sciences, up from $10000.0 in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $89.0 million in Q4 2025 to a low of $10000.0 in Q3 2025.
• A 5-year average of $71.5 million and a median of $79.0 million in 2023 frame the typical range for Shares Outstanding (Weighted Average).
• Across the five-year window, Shares Outstanding (Weighted Average) surged 22823.98% in 2023 and sank 99.99% in 2025, its largest moves.
• Anavex Life Sciences' Shares Outstanding (Weighted Average) stood at $76.0 million in 2021, then grew by 2.6% to $78.0 million in 2022, then advanced by 5.26% to $82.1 million in 2023, then grew by 3.32% to $84.8 million in 2024, then grew by 4.98% to $89.0 million in 2025.
• According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $89.0 million, $10000.0, and $85.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison